Biographical Sketch
Manjula Gupta, M.Sc., Ph.D., received her M.Sc. and Ph.D. degrees from Agra University, India, and she received her postgraduate training at Cleveland Clinic. She is the Medical Director of the Endocrine, Immunology and Cancer markers Laboratory, in the Department of Clinical Pathology at Cleveland Clinic, and she has a secondary appointment in the Department of Endocrinology. She also holds a faculty positions as Associate Professor in the Department of Clinical Pathology at Cleveland Clinic Lerner College of Medicine and as Adjunct Clinical Professor in the Department of Clinical Chemistry, Cleveland State University.
Her major areas of research include endocrine autoimmunity and the role of hormones in the regulation of breast and prostate and thyroid cancer growth. She is a member of numerous professional societies, including the Endocrine Society, American Thyroid Association, American Association of Immunologists and American Association for Cancer Research, American Association of Clinical Chemists and American Diabetes Association. She is a fellow of National Academy of Clinical Biochemists.
Dr. Gupta has authored or coauthored 16 book chapters and review articles, 96 peer-reviewed manuscripts and 170 abstracts in various scientific journals. Her lab provides analysis of all endocrine tests autoantibodies as well as of biochemical markers of cancer as routine diagnostic procedures.
Specialty Interests
endocrine aspects of cancer, endocrine immunology, immunoassays
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/6/2008, Dr.
Gupta has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Gupta receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Hybrid Diagnostics Inc.
Royalty Payments. Dr. Gupta has the right to receive royalty payments for inventions or discoveries related to the companies shown below:
Hybrid Diagnostics Inc.
